Literature DB >> 28575732

Extra precision docking, free energy calculation and molecular dynamics studies on glutamic acid derivatives as MurD inhibitors.

Mohammed Afzal Azam1, Srikanth Jupudi2.   

Abstract

The binding modes of well known MurD inhibitors have been studied using molecular docking and molecular dynamics (MD) simulations. The docking results of inhibitors 1-30 revealed similar mode of interaction with Escherichia coli-MurD. Further, residues Thr36, Arg37, His183, Lys319, Lys348, Thr321, Ser415 and Phe422 are found to be important for inhibitors and E. coli-MurD interactions. Our docking procedure precisely predicted crystallographic bound inhibitor 7 as evident from root mean square deviation (0.96Å). In addition inhibitors 2 and 3 have been successfully cross-docked within the MurD active site, which was pre-organized for the inhibitor 7. Induced fit best docked poses of 2, 3, 7 and 15/2Y1O complexes were subjected to 10ns MD simulations to determine the stability of the predicted binding conformations. Induce fit derived docked complexes were found to be in a state of near equilibrium as evident by the low root mean square deviations between the starting complex structure and the energy minimized final average MD complex structures. The results of molecular docking and MD simulations described in this study will be useful for the development of new MurD inhibitors with high potency.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Extra precision docking; Induced fit docking; Molecular dynamics; MurD inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28575732     DOI: 10.1016/j.compbiolchem.2017.05.004

Source DB:  PubMed          Journal:  Comput Biol Chem        ISSN: 1476-9271            Impact factor:   2.877


  1 in total

1.  Dipeptidyl peptidase-IV inhibitory action of Calebin A: An in silico and in vitro analysis.

Authors:  Nehru Sai Suresh Chalichem; Srikanth Jupudi; Venkata Ramesh Yasam; Duraiswamy Basavan
Journal:  J Ayurveda Integr Med       Date:  2021-10-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.